Electrophysiology Mapping and Ablation Devices – Market Insights – Latin America

The Latin American EP mapping and ablation device market will experience strong growth as a result of favorable demographic trends and the introduction of product innovations. However, the COVID-19 global pandemic has resulted in lost procedure volumes in the short term, followed by a period of recovery.

This Medtech 360 Report provides comprehensive data and analysis on the state of the market for EP mapping and ablation devices in the Latin American region from 2019 to 2031.

The COVID-19 pandemic had a significant impact on the Latin American EP mapping and ablation device market.

Which procedures were the most impacted in Latin America?

At what pace are procedures recovering, and by when will growth trends return to prepandemic patterns?

Due to increasing procedure volumes, AF treatment continues to be a focus among electrophysiologists.

How fast are AF treatment volumes growing, and how the growth rate differ from the other arrhythmia types?

What factors are driving AF treatment volume growth?

How are physicians’ AF procedure preferences changing?

The EP diagnostic and ablation catheter segments account for significant market revenues.

What new technologies will enter the market going forward, and when are they expected to be launched?

What are the changing catheter preferences among electrophysiologists?

In which markets are competitors benefiting most directly from growth trends?

Cost sensitivity and device reusability continue to affect Latin American EP mapping and ablation device market growth.

How does device reuse impact the EP catheter market in Latin America?

Which catheters are reused and what effect does device reuse have on market revenues?

How will device reuse trends change over the forecast period?

Table of contents